Home BancShares' Donna Townsell Breaks the Glass Ceiling
CONWAY, Ark., Feb. 08, 2019 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NASDAQ GS: HOMB) (“Home” or “the Company”), and its […]
Aura Health Announces Pricing of Previously Announced $5.0 Million Brokered Subscription Receipt Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN […]
Restoration Robotics Announces Presentation on ARTAS iX™ at the South Beach Symposium in Miami
Presentation to be Led by Dr. Paul Rose of the Miami Hair and Skin Institute following the Recent Installation of […]
Key Process Equipment Delivered for the Lac Guéret Project
MONTREAL, Feb. 08, 2019 (GLOBE NEWSWIRE) — Mason Graphite Inc. (“Mason Graphite” or the “Company”) (TSX.V: LLG; OTCQX: MGPHF) is […]
Biome Grow announces first shipment of finished product to Newfoundland and Labrador
TORONTO, Feb. 08, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTCQB: BIOIF) […]
R1 Develops Technology and Innovation Center in Collaboration with Intermountain Healthcare
State-of-the-art development, training and education facility to foster RCM innovation to drive financial results for healthcare providers and improve the […]
Tabula Rasa HealthCare to Present at HIMSS19
TRHC to debut state-of-the-art SMART on FHIR integration to expand access to its proven Medication Risk Mitigation technology in the […]
Donegal Group Inc. Announces Preliminary Results for 2018 Fourth Quarter and Highlights Changes to 2019 Reinsurance Program
MARIETTA, Pa., Feb. 08, 2019 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) today announced preliminary results of operations […]
Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
Results from the study demonstrate that subcutaneous MarzAA (FVIIa) significantly reduces both annualized bleed rate and the percentage of days […]
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2018 Financial Results Conference Call and Webcast
CAMBRIDGE, Mass., Feb. 08, 2019 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and […]
